Diabetes: The New Approach |
From inside the book
Results 1-3 of 11
Page 115
... Phenformin Phenformin , the other type of oral medication used in diabetes , also has a definite hypoglycemic effect . The de- velopment of the ancestor of phenformin actually antedated that of the sulfonylureas and even the discovery ...
... Phenformin Phenformin , the other type of oral medication used in diabetes , also has a definite hypoglycemic effect . The de- velopment of the ancestor of phenformin actually antedated that of the sulfonylureas and even the discovery ...
Page 116
... phenformin was introduced for clinical trial . The chemical manipulations that resulted in the creation of phenformin removed the marked liver and kidney toxicity but retained the hypoglycemic action . Although there is less exact ...
... phenformin was introduced for clinical trial . The chemical manipulations that resulted in the creation of phenformin removed the marked liver and kidney toxicity but retained the hypoglycemic action . Although there is less exact ...
Page 118
... phenformin in combination with the sul- fonylureas has been advocated for a number of years and has achieved a measure of success in overcoming secondary failures experienced with the sulfonylureas alone . When it has been deemed ...
... phenformin in combination with the sul- fonylureas has been advocated for a number of years and has achieved a measure of success in overcoming secondary failures experienced with the sulfonylureas alone . When it has been deemed ...
Contents
The Pathophysiology of Diabetes | 20 |
Complications of Insulin Therapy | 88 |
Oral Antidiabetic Medication | 109 |
Copyright | |
3 other sections not shown
Common terms and phrases
abnormalities acids action activity addition allows amounts artery associated attitude basement membrane believe beta cells blood sugar blood vessels body called calorie capillary carbohydrate cause chemical clinical combination complications considerable continuous course diet dietary discussion disease disorder drugs early effect elevated evidence excessive exists experience fact factors fetus follow function glucose greater heart hormone hypoglycemia important incidence increased individual injection insulin involved kidney less levels liver loss lower major maturity-onset diabetic means metabolic muscle nature nerve nondiabetic normal obesity observed occurs oral pancreas patient percent period person physician placenta possible pregnancy present problem produce progressive proper protein reason recent reduced referred require resistance response result secretion severe skin specific stimulation substance suggest sulfonylureas supply symptoms therapy tion tissue tolerance treatment understanding units urine usually wall weight